You are searching for: hsa04217

---

T95371 Target Info	Target Name	Interferon alpha/beta receptor 1 (IFNAR1)
	Target type	Clinical trial Target
	Disease	Hepatitis B virus infection; Ovarian cancer;
	Drugs	EMZ701	Drug Info

T99340 Target Info	Target Name	Receptor-interacting protein 1 (RIPK1)
	Target type	Clinical trial Target
	Disease	Cutaneous lupus erythematosus; Plaque psoriasis;
	Drugs	GSK2982772	Drug Info

T99397 Target Info	Target Name	Voltage-dependent anion-selective channel 1 (VDAC1)
	Target type	Clinical trial Target
	Disease	Actinic keratosis;
	Drugs	VDA-1102	Drug Info

T64774 Target Info	Target Name	Voltage-dependent anion-selective channel 3 (VDAC3)
	Target type	Clinical trial Target
	Disease	Solid tumour/cancer;
	Drugs	PRLX93936	Drug Info

T08156 Target Info	Target Name	Interferon-alpha 5 (IFNA5)
	Target type	Clinical trial Target
	Disease	Hepatitis C virus infection; Infectious disease;
	Drugs	Interferon alpha 5	Drug Info

T08499 Target Info	Target Name	Caterpiller protein 1.1 (NLRP3)
	Target type	Clinical trial Target
	Disease	Musculoskeletal pain; Acute gout flare;
	Drugs	Dapansutrile	Drug Info

T98062 Target Info	Target Name	Glycogen phosphorylase muscle form (GP)
	Target type	Patented-recorded Target
	Disease	Metabolic syndrome x; Type-2 diabetes;
	Drugs	URSOLIC ACID	Drug Info

T16042 Target Info	Target Name	Arachidonate 15-lipoxygenase (15-LOX)
	Target type	Patented-recorded Target
	Disease	Not Available
	Drugs	Triazole derivative 3	Drug Info

T15700 Target Info	Target Name	Caspase-8 (CASP8)
	Target type	Patented-recorded Target
	Disease	Autoimmune diabetes; Solid tumour/cancer;
	Drugs	Amooranin	Drug Info

T00663 Target Info	Target Name	Stress-activated protein kinase JNK3 (JNK3)
	Target type	Patented-recorded Target
	Disease	Central nervous system injury;
	Drugs	7-azaindole derivative 6	Drug Info

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.